Previous 10 | Next 10 |
Sunesis Pharmaceuticals (SNSS) soars 48% in premarket, after announcing a reverse merger agreement with a privately-held Viracta Therapeutics. The new organization will do business under the Viracta moniker and intends to be listed on the Nasdaq under the ticker symbo...
Merger to c reate Nasdaq-listed company focused on developing Viracta’s precision oncology pipeline targeting virus-associated malignancies Registration trial for Viracta’s lead program in Epstein-Barr virus (EBV)- positive lymph...
Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results Conference Call November 16, 2020 04:30 PM ET Company Participants Par Hyare - SVP, Commercial Dayton Misfeldt - Dayton Misfeldt Judy Fox - Chief Scientific Officer and EVP, Research & Development Conference Call Participants Justin Kim...
Sunesis Pharmaceuticals (SNSS): Q3 GAAP EPS of -$0.29 beats by $0.06.Cash and equivalents totaled $26M.Shares -0.77%.Press Release For further details see: Sunesis Pharmaceuticals EPS beats by $0.06
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the third quarter ended September 30, 2020. Loss from operations for the three months ended September 30, 2020 was $4.5 million. As...
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16 th , 2020 at 4:30pm Eastern Time to discuss corporate updates and financial results for the third q...
Air Industries Group (AIRI) +53% on Q3 results.Equillium (EQ) +24% after FDA gives green signal to it's late-stage COVID-19 trial.BioLineRx (BLRX) +24% on positive late-stage data on lead candidate.Trevena (TRVN) +20%.Miragen Therapeutics (MGEN) +12%.Aldeyra Ther...
Does The Price Of These Penny Stocks Matter To These Analysts? Whether you’re a day trader or looking for how to invest in penny stocks certain things are important to keep in mind. First and most important is the risk profile you have. Can you handle big swings in price or d...
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 32 nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held October 24-25, 2020 in a virtual format. ...
Are You Watching These 4 Penny Stocks Right Now? Many traders who buy penny stocks for a living tend to hate the weekend. That’s because the market’s closed. But it doesn’t have to be all bad either. Consider this a time to pause, reflect on the week, and look a...
News, Short Squeeze, Breakout and More Instantly...
Viracta Therapeutics Inc Com Company Name:
SNSS Stock Symbol:
NASDAQ Market:
Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement Shares of Viracta to commence trading on the Nasdaq Global Select Market on February 25, 2021 under ticker symbol 'VIRX' Cash and cash equivalents of over $120 million as...
There’s Blood In The Streets, But Opportunity Could Be Presenting Itself With Penny Stocks What’s your strategy for finding the best penny stocks to buy ? At the top of my mind, there are a few things to look at. One of them is industry sentiment. Several industries ha...
Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma Resulting patent to extend Viracta's intellectual property protection into at least 20...